Downstream Processing Featured Articles

  1. Company Recognized For Outstanding Contributions To The Pharmaceutical Sciences 5/30/2012

     Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that The American Association of Pharmaceutical Scientists (AAPS) has awarded its 2012 Excellence in Ligand Binding Assays Award to the Bioanalytical Development group from Morphotek for their abstract, “Development and Validation of a Pharmacokinetic Assay on the Gyrolab Platform for Use in Phase II/III Clinical Studies.” The award was presented at the AAPS 2012 National Biotechnology Conference held May 21-23 in San Diego.
     

  2. Additional Details Concerning Issue Of Shares To Johnson & Johnson Development Corporation As Part Of The Daratumumab Agreement 8/30/2012

    Genmab A/S announced recently additional details concerning the subscription of shares by Johnson & Johnson Development Corporation (JJDC) as part of the global license and development agreement for daratumumab (HuMax-CD38) between Genmab (see Genmab's Company Announcement 20) and Janssen Biotech, Inc., one of the Janssen Pharmaceutical companies of Johnson & Johnson.

  3. RainDance Technologies And CLC Bio Collaborate To Develop Specialized Software Solutions For Targeted Resequencing 9/18/2009
    RainDance Technologies and CLC bio recently announced a partnership to develop specialized software for the analysis of targeted resequencing data generated by workflows incorporating RainDance’s Sequence Enrichment Solution and next-generation DNA sequencing platforms.
  4. Colder Products Company Presents 'Validating Single-Use Connections' At Interphex 2007 4/25/2007
    Colder Products Company is spotlighting single-use connections at Interphex 2007 (booth #3037), Jacob Javits Convention Center, New York, April 24-26
  5. Therapure Announces Opening Of Custom Biologics Manufacturing Wing 4/20/2012

    Recently marked the official opening of Therapure Biopharma Inc.’s Custom Biologics Manufacturing Wing, which supports the development and manufacture of innovative medical treatments.

  6. How Hepatitis C Invades The Body 12/27/2012

    Researchers at the University of Colorado School of Medicine have figured out intimate details of how the hepatitis C virus takes over an invaded cell, a breakthrough that could point to way for new treatments for the virus.

  7. Singapore Single-Cell Research Center Opens Door For Asian Biological Discoveries 4/15/2013

    Government officials, academic, and industry leaders gathered to celebrate the official opening of the Single-Cell Omics Centre (SCOC) in Singapore today. It is the first research centre in Asia exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through insight derived from single cells.

  8. CellCentric And ZoBio Enter Into Partnership To Develop Lead Compounds Against Epigenetic Drug Targets 6/20/2012

    ZoBio and CellCentric are pleased to announce that the companies are working together to discover lead compounds against CellCentric’s portfolio of epigenetic therapeutic drug targets. ZoBio will use its proprietary TINS technology to screen its fragment library against targets nominated by CellCentric. Hit to lead and lead optimisation activities will be further supported by ZoBio’s biophysical and medicinal chemistry research services.

  9. Scientists Discover Why Some Proteins Are Speedier Than Others 3/11/2013

    Scientists at the University of Bath have solved a problem that has frustrated biologists for years – why different parts of proteins are made at different rates.

  10. How Can You Mitigate The Risks Of Single-Use Bags? 8/24/2015

    The loss of product as a result of bag failure isn’t just an annoyance; it’s an expense, and a costly one at that. However, Chuck Hart, director of manufacturing at Prolong Pharmaceuticals, says with proper fitting and handling, these concerns can be mitigated.